Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis
NCT00417339 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2016-05-13
Summary
Study on intradialytic kinetics of protein-bound uremic retention solutes during long nocturnal hemodialysis
Conditions
Interventions
- PROCEDURE
-
hemodialysis
individualised
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Björn KI Meijers, MD · Universitaire Ziekenhuizen KU Leuven
-
Pieter Evenepoel, MD, PhD · Universitaire Ziekenhuizen KU Leuven
-
Tom Dejagere, MD · Virga Jesse Ziekenhuis
-
Nigel Toussaint, MD · Geelong Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Australia
- Belgium
Study Locations
More Related Trials
-
Peritoneal Dialysis Versus Haemodialysis
NCT00752583 ·Status: COMPLETED ·Phase: NA
-
The Use of Low Molecular Weight Heparin in Hemodiafiltration
NCT00756145 ·Status: COMPLETED ·Phase: PHASE4
-
Coupling Between Clotting Characteristics in Chronic Hemodialysis Patients and the Hemodialyzer Patency
NCT05440201 ·Status: COMPLETED ·Phase: NA
-
Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function
NCT00442299 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis
NCT00433264 ·Status: COMPLETED
-
Effect of Sodium and UF Profiling on Dialysis
NCT06213129 ·Status: NOT_YET_RECRUITING
-
Association of Survival in Impact of Ultrafiltration Rates in Hemodialysis Patients
NCT03471299 ·Status: COMPLETED
-
Non- Clinical Coagulation Activation During Hemodialysis
NCT04063423 ·Status: COMPLETED
-
Clinical and Biochemical Effects of Multipass Hemodialysis
NCT01267760 ·Status: COMPLETED ·Phase: PHASE2
-
Anticoagulation in Chronic Hemodialysis Patients Versus Hemodialyzer Fiber Patency, Bleedings and Quality of Life
NCT05365542 ·Status: COMPLETED
-
Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
NCT01327391 ·Status: COMPLETED ·Phase: PHASE4
-
Dialysis Performance of the FX CorAL Membrane
NCT06203795 ·Status: COMPLETED ·Phase: NA
-
Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration
NCT01923961 ·Status: COMPLETED ·Phase: NA
-
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
NCT07348536 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
NCT03874117 ·Status: COMPLETED ·Phase: NA
-
Serum Ceftazidime Concentrations in Hemodialysis Patients
NCT03634904 ·Status: UNKNOWN ·Phase: NA
-
Effects of Variation of Sodium Dialysate in ICU
NCT03329313 ·Status: RECRUITING ·Phase: PHASE2
-
Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients
NCT06002529 ·Status: UNKNOWN ·Phase: NA
-
Solute Removal With High Volume Hemodiafiltration Versus Long High Flux Hemodialysis
NCT01445366 ·Status: COMPLETED ·Phase: NA
-
Microcirculation During Haemodialysis
NCT01396980 ·Status: COMPLETED
-
The Effect of Nocturnal Haemodialysis on Arterial Stiffness
NCT00641875 ·Status: COMPLETED
-
Removal of Protein Bound Uremic Toxins by Modified Plasma Separation and Adsorption Combined With Hemodialysis
NCT00375635 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)
NCT02287493 ·Status: COMPLETED
-
Conventional Hemodialysis vs. Short Daily Hemodialysis (6 Days / Week) and Mechanisms of Blood Pressure Control
NCT00759967 ·Status: COMPLETED ·Phase: NA
-
Blood Volume Analysis and Related Outcomes in Hemodialysis
NCT01679249 ·Status: COMPLETED